Correlation Between Collplant Biotechnologies and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Collplant Biotechnologies and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collplant Biotechnologies and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collplant Biotechnologies and Checkpoint Therapeutics, you can compare the effects of market volatilities on Collplant Biotechnologies and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collplant Biotechnologies with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collplant Biotechnologies and Checkpoint Therapeutics.
Diversification Opportunities for Collplant Biotechnologies and Checkpoint Therapeutics
-0.89 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Collplant and Checkpoint is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Collplant Biotechnologies and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Collplant Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collplant Biotechnologies are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Collplant Biotechnologies i.e., Collplant Biotechnologies and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Collplant Biotechnologies and Checkpoint Therapeutics
Given the investment horizon of 90 days Collplant Biotechnologies is expected to generate 0.71 times more return on investment than Checkpoint Therapeutics. However, Collplant Biotechnologies is 1.4 times less risky than Checkpoint Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 397.00 in Collplant Biotechnologies on August 26, 2024 and sell it today you would earn a total of 17.00 from holding Collplant Biotechnologies or generate 4.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Collplant Biotechnologies vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Collplant Biotechnologies |
| Checkpoint Therapeutics |
Collplant Biotechnologies and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Collplant Biotechnologies and Checkpoint Therapeutics
The main advantage of trading using opposite Collplant Biotechnologies and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collplant Biotechnologies position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Collplant Biotechnologies vs. Eliem Therapeutics | Collplant Biotechnologies vs. HCW Biologics | Collplant Biotechnologies vs. Scpharmaceuticals | Collplant Biotechnologies vs. Milestone Pharmaceuticals |
| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |